Jun 29, 2026 07:00AM
Jun 29, 2026 07:00AM
May 6, 2026 07:05AM
May 6, 2026 07:00AM
May 4, 2026 07:01AM
May 4, 2026 07:00AM
Apr 15, 2026 07:00AM BioCryst to Report First Quarter 2026 Financial Results on May 6
Apr 6, 2026 07:00AM
Apr 6, 2026 07:00AM
Feb 26, 2026 07:58AM
Feb 26, 2026 07:00AM
Feb 5, 2026 07:01AM
Jan 23, 2026 09:00AM
Jan 23, 2026 09:00AM BioCryst Completes Acquisition of Astria Therapeutics, Expanding Leadership in Hereditary Angioedema 
Jan 12, 2026 07:04AM
Jan 12, 2026 07:00AM
Nov 16, 2025 03:00PM
Nov 12, 2025 08:00AM
Nov 4, 2025 09:12AM
Nov 3, 2025 07:03AM
Nov 3, 2025 07:00AM BioCryst Reports Third Quarter 2025 Financial Results and Provides Business Update
Oct 20, 2025 07:00AM
Oct 14, 2025 07:00AM
Oct 14, 2025 07:00AM
Sep 11, 2025 08:59AM
Aug 4, 2025 07:01AM
Aug 4, 2025 07:00AM
Jul 31, 2025 07:00AM BioCryst names Charlie Gayer as next CEO after Jon Stonehouse retires
Jul 31, 2025 07:00AM
Jul 24, 2025 12:20PM
Jul 21, 2025 07:00AM
Jul 7, 2025 07:01AM
Jul 7, 2025 07:00AM
May 5, 2025 07:02AM
May 5, 2025 07:00AM BioCryst Reports First Quarter 2025 Financial Results and Provides Business Update
May 1, 2025 07:02AM
May 1, 2025 07:00AM
Apr 21, 2025 07:00AM
Apr 12, 2025 04:00AM
Feb 24, 2025 07:29AM
Feb 24, 2025 07:00AM
Feb 10, 2025 07:00AM BioCryst to Report Fourth Quarter 2024 Financial Results on February 24
Jan 10, 2025 07:01AM
Jan 10, 2025 07:00AM
Nov 4, 2024 07:04AM
Nov 4, 2024 07:00AM
Oct 21, 2024 07:00AM
Sep 17, 2024 07:06AM
Sep 17, 2024 07:00AM BioCryst and the pan-Canadian Pharmaceutical Alliance (pCPA) Successfully Complete Negotiations for ORLADEYO® (berotralstat), an Oral, Once-daily Therapy for the Prevention of Hereditary Angioedema A
Aug 5, 2024 07:02AM

1,201,708 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All